JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorgani, N. N.
Right arrow Articles by Altin, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorgani, N. N.
Right arrow Articles by Altin, J. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 42, 29633-29640, October 15, 1999

Differential Binding of Histidine-rich Glycoprotein (HRG) to Human IgG Subclasses and IgG Molecules Containing kappa  and lambda  Light Chains

Nick N. GorganiDagger , Christopher R. ParishDagger , and Joseph G. Altin§

From the Dagger  Division of Immunology and Cell Biology, The John Curtin School of Medical Research and § Division of Biochemistry and Molecular Biology, School of Life Sciences, Faculty of Science, The Australian National University, Canberra, Australian Capital Territory, 0200, Australia

In previous studies we showed that the plasma protein histidine-rich glycoprotein (HRG) binds strongly to pooled human IgG. In the present work myeloma proteins consisting of different human IgG subclasses were examined for their ability to interact with human HRG. Using an IAsys optical biosensor we found initially that IgG subclasses differ substantially in their affinity of interaction with HRG. However, the most striking finding was the observation that the kinetics of the HRG interaction was dramatically affected by whether the IgG subclasses contained the kappa  or lambda  light (L)-chains. Thus, the on-rate for the binding of HRG to the kappa  L-chain containing IgG1 and IgG2 (IgG1kappa and IgG2kappa ) was ~4- and ~10-fold faster than that for the binding of HRG to lambda  L-chain containing IgG1 and IgG2 (IgG1lambda and IgG2lambda ), respectively, with the dissociation constants (Kd) in the range 3-5 nM and 112-189 nM for the kappa  and lambda  isoforms, respectively. In contrast, the on-rate for the binding of HRG to IgG3kappa and IgG4kappa was found to be 9- and 20-fold slower than that for the binding of HRG to IgG3lambda and IgG4lambda , respectively, with the Kd in the range 147-268 nM and 96-109 nM for the kappa  and lambda  isoforms, respectively. The binding of HRG to immunoglobulins containing the kappa  L-chain (particularly IgG1kappa ) was generally potentiated in the presence of a physiological concentration (20 µM) of Zn2+ (Kd decreased to 0.60 ± 0.01 for IgG1kappa ), but Zn2+ had no effect or slightly inhibited the binding of HRG to immobilized IgG subclasses possessing the lambda  L-chain. Interestingly, HRG also bound differentially to Bence Jones (BJ) proteins containing kappa  and lambda  L-chains, with HRG having a 14-fold lower Kd for BJkappa than for BJlambda when 20 µM Zn2+ was present. HRG also bound to IgM (IgMkappa ), but the affinity of this interaction (Kd ~1.99 ± 0.05 µM) was markedly lower than the interaction with IgG, and the affinity was actually decreased 4-fold in the presence of Zn2+. The results demonstrate that both the heavy (H)- and L-chain type have a profound effect on the binding of HRG to different IgG subclasses and provide the first evidence of a functional difference between the kappa  and lambda  L-chains of immunoglobulins.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. M. Dillon, M. S. Ricci, C. Vezina, G. C. Flynn, Y. D. Liu, D. S. Rehder, M. Plant, B. Henkle, Y. Li, S. Deechongkit, et al.
Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass
J. Biol. Chem., June 6, 2008; 283(23): 16206 - 16215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Jones, I. K. H. Poon, M. D. Hulett, and C. R. Parish
Histidine-rich Glycoprotein Specifically Binds to Necrotic Cells via Its Amino-terminal Domain and Facilitates Necrotic Cell Phagocytosis
J. Biol. Chem., October 21, 2005; 280(42): 35733 - 35741.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Jones, M. D. Hulett, J. G. Altin, P. Hogg, and C. R. Parish
Plasminogen Is Tethered with High Affinity to the Cell Surface by the Plasma Protein, Histidine-rich Glycoprotein
J. Biol. Chem., September 10, 2004; 279(37): 38267 - 38276.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Jones, M. D. Hulett, and C. R. Parish
Histidine-rich Glycoprotein Binds to Cell-surface Heparan Sulfate via Its N-terminal Domain following Zn2+ Chelation
J. Biol. Chem., July 16, 2004; 279(29): 30114 - 30122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Tsurupa, B. Ho-Tin-Noe, E. Angles-Cano, and L. Medved
Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) {alpha}C-domains
J. Biol. Chem., September 26, 2003; 278(39): 37154 - 37159.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. N. Gorgani, B. A. Smith, D. H. Kono, and A. N. Theofilopoulos
Histidine-Rich Glycoprotein Binds to DNA and Fc{gamma}RI and Potentiates the Ingestion of Apoptotic Cells by Macrophages
J. Immunol., November 1, 2002; 169(9): 4745 - 4751.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. P. Manderson, M. C. Pickering, M. Botto, M. J. Walport, and C. R. Parish
Continual Low-Level Activation of the Classical Complement Pathway
J. Exp. Med., September 10, 2001; 194(6): 747 - 756.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
L. MEDVED, G. TSURUPA, and S. YAKOVLEV
Conformational Changes upon Conversion of Fibrinogen into Fibrin: The Mechanisms of Exposure of Cryptic Sites
Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 185 - 204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.